🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesGLP-1 and gluconeogenesis — 12 month update

GLP-1 and gluconeogenesis — 12 month update

amsterdam_pete Sun, Mar 31, 2024 at 6:17 AM 9 replies 1,918 viewsPage 1 of 2
This thread is more than 23 months old. Information may be outdated. Consider searching for more recent discussions.
amsterdam_pete
Senior Member
1,567
6,789
Feb 2024
Netherlands
Mar 31, 2024 at 7:42 AM#1

GLP-1 and gluconeogenesis — 12 month update

I've written this guide because I keep seeing the same questions come up about GLP-1 and gluconeogenesis 12 month update. Rather than repeating myself across threads, here's everything in one place.

Who this is for: Anyone interested in glp-1 and gluconeogenesis 12 month update, whether you're a newcomer or looking to deepen your understanding.

1. Overview

GLP-1 and gluconeogenesis 12 month update is an important topic in the metabolic health & diabetes space. Understanding the fundamentals will help you make more informed decisions and have better conversations with your healthcare provider.

2. What the evidence says

The clinical trial data is extensive. Multiple randomized controlled trials (STEP, SURMOUNT, SUSTAIN, SURPASS programs) have established clear efficacy and safety benchmarks. I'll reference specific data points throughout this guide.

3. Practical recommendations

  • Start with the basics — don't overcomplicate things early on
  • Track your own data systematically (weight, labs, side effects)
  • Consult your healthcare provider before making any changes
  • Use this community as a supplement to — not a replacement for — professional medical care

4. Common mistakes

The most common errors I see: rushing titration, inadequate protein intake, not getting baseline labs, and relying on anecdotal reports over clinical data.

This guide is educational. It does not constitute medical advice. Last updated March 2026.

— amsterdam_pete | Metabolic Health & Diabetes
25 0JakeSmashed95, NauseaFreeNow, SteveThurs and 22 others
Reply Quote Save Share Report
PurityPaulOR
Senior Member
1,890
7,890
Mar 2024
Oregon
Mar 31, 2024 at 7:59 AM#2

Good question. For GLP-1 and gluconeogenesis 12 month, here is what the evidence says:

  • The clinical trial data (STEP program) supports this approach
  • Real-world results from this community generally confirm the trial findings
  • Individual variation is real — give it at least 8 weeks before judging

Happy to go deeper on any of these points if helpful.

Last edited: Mar 31, 2024 at 10:59 AM
27 16MikeNYC_runner and 24 others
Reply Quote Save Share Report
RickReta_CO
Member
312
1,234
Jan 2025
Colorado
Mar 31, 2024 at 8:16 AM#3

PurityPaulOR nailed it. Building on that — GLP-1 and gluconeogenesis 12 month is something I discuss with my dietitian regularly, and their clinical perspective aligns with what PurityPaulOR described.

One thing I would add: discussing this with your provider early helps.

40 11hyun_seoul, jim_asheville, matt_MKE and 37 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
CanadaChris
Member
234
890
Nov 2024
Toronto, CA
Mar 31, 2024 at 8:33 AM#4

100%. My provider said the same thing about GLP-1 and gluconeoge.

19 0Dr.PulmRoch, maya_sedona, stefan_berlin and 16 others
Reply Quote Save Share Report
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Mar 31, 2024 at 8:50 AM#5

Clinical perspective on GLP-1 and gluconeogenesis 12 month:

I have managed roughly 300 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that the medication works best as part of a comprehensive approach.

For this specific question, I would recommend: getting comprehensive baseline labs first.

4 12MeganSA_TX, LarryQC_SD, wanda_boise and 1 other
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register